Title: |
Chinese Ophthalmological Society guideline for initiating treatment in adults with polypoidal choroidal vasculopathy |
Edition: |
Original |
Classification: |
Standard guideline |
Field: |
Treatment |
Countries and regions: |
China |
Guidelines users: |
Chinese ophthalmologist and policy-makers |
Evidence classification method: |
GRADE (grades of recommendations assessment, development, and evaluation) |
Development unit: |
Chinese Ophthalmological Society |
Registration time: |
2021-01-08 |
Registration number: |
IPGRP-2021CN005 |
Purpose of the guideline: |
Promote the use of best treatment for adults with polypoidal choroidal vasculopathy, to improve clinical outcomes and patient benefit |